COVID-19 Research
In silico analysis of 10000 genomic sequences of COVID-19 around the world including India to identify genetic variability and potential molecular targets in virus and human
A phase II B open label randomised controlled trial to evaluate the efficacy and safety of Ivermectin in reducing viral loads in patients with hematological disorders who are admitted with COVID-19 infection (ICE study)
Rapid, PCR or antibody-free clinical diagnosis of viral infection via ‘chemical-nose’ sensor
Development of machine learning-based drug repurposing pipeline against SARS-CoV-2 and human proteome
An easy and rapid detection platform for viral diseases from saliva: COVID-19 and beyond
Development of a point-of-care fibre-optic biosensor (P-FAB) device for rapid detection of COVID-19
Targeting the RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2 for the development of inhibitors
Understanding the role of SARS-CoV-2 virulence factor-Orf3a in modulating host cell responses: A way to identify host-directed therapy
Structural, biochemical and computational investigation on the therapeutic targets of SARS-CoV-2 and structure-based drug discovery from Indian herbs
Development of a portable optical cavity sterilisation unit
Pages
